Pharsight

CHUGAI PHARMACEUTICAL CO LTD PATENTS FACING OPPOSITIONS

Top patents of CHUGAI PHARMACEUTICAL CO LTD facing oppositions at the European Patent Office (EPO).

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP3378486B1 03 Mar, 2021 Stabilized antibody-containing liquid formulations Jan, 2031 5
EP2647707B1 12 Sep, 2018 Cytotoxicity-inducing therapeutic agent Nov, 2031 5
EP2154244B1 12 Apr, 2017 Cell culture method using amino acid-enriched medium Apr, 2028 5
EP3130606B1 13 Oct, 2021 Immunoactivating bispecific antibodies Apr, 2035 2
EP3056568B1 15 Sep, 2021 Methods for controlling blood pharmacokinetics of antibodies Mar, 2027 2
EP3342786B1 23 Jun, 2021 Anti-dll3 antibody Jan, 2031 2
EP2698431B1 09 Sep, 2020 Retention of antigen-binding molecules in blood plasma and method for modifying immunogenicity Mar, 2032 2
EP3330279B1 06 Apr, 2022 Method for purifying composition comprising antibodies with anionic polymer Jul, 2036 1
EP3296395B1 30 Jun, 2021 Multiple antigen binding molecular fusion, pharmaceutical composition, method for identifying linear epitope, and method for preparing multiple antigen binding molecular fusion May, 2036 1
EP2787078B1 22 May, 2019 Antigen-binding molecule having regulated conjugation between heavy-chain and light-chain Oct, 2032 1
EP2526963B1 25 Apr, 2018 Stabilized Antibody-Containing Liquid Formulations Jan, 2031 1
EP2311492B1 04 Oct, 2017 Antibody-containing stabilized preparations Aug, 2021 1